|
 |
REVIEW ARTICLE |
|
Year : 2019 | Volume
: 8
| Issue : 11 | Page : 3496-3503 |
|
|
The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics
Dalal I Alesa1, Haidar M Alshamrani2, Yahya A Alzahrani3, Dania N Alamssi4, Nada S Alzahrani2, Marwan E Almohammadi5
1 Dermatology Resident, Alnoor Specialist Hospital, Makkah, Saudi Arabia 2 Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia 3 Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia 4 General Practitioner, Consultant Center for Dermatology and Venereology Clinics, Makkah, Saudi Arabia 5 Faculty of Medicine, Albaha University, Albaha, Saudi Arabia
Date of Submission | 28-Aug-2019 |
Date of Decision | 17-Sep-2019 |
Date of Acceptance | 04-Oct-2019 |
Date of Web Publication | 15-Nov-2019 |
Correspondence Address: Dr. Yahya A Alzahrani Faculty of Medicine, King Abdulaziz University, Jeddah Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jfmpc.jfmpc_709_19
The adult intestine hosts a huge number of diverse bacterial species, collectively referred to as the microbiome, that reside mainly in the lower gut, where they maintain a symbiotic relationship with their host. Recent research points to a central role of the microbiome in many biological processes. These microbial communities are influenced by multiple environmental and dietary factors and can modulate immune responses. In addition to local effects on the gastrointestinal tract, the microbiota is associated with effects on other organs and tissues, such as the skin. Indeed, an altered microbiome has been associated with skin disorders in several instances. Thus, in this review, we describe the recent advances regarding the interplay between gut microbiota and the skin. We explore how this potential link affects skin homeostasis and its influence on modulating the cutaneous immune response, focusing on psoriasis disorder. Finally, we discuss how to take advantage of this interplay to manage this disorder, particularly through probiotics administration. In the gastrointestinal tract, the microbiome has been proven to be important in the maintenance of the balance between effector T cells and regulatory T cells, and the induction of immunoglobulin A. Moreover, gut bacterial dysbiosis is associated with chronic inflammatory disorders of the skin, such as psoriasis. Thus, the microbiome can be considered an effective therapeutical target for treating this disorder. Despite some limitations, interventions with probiotics seem promising for the development of a preventive therapy by restoring altered microbiome functionality or as an adjuvant in specific immunotherapy.
Keywords: Autoimmune disease, cytokine, inflammation, Lactobacillus, regulatory T cells, short-chain fatty acid
How to cite this article: Alesa DI, Alshamrani HM, Alzahrani YA, Alamssi DN, Alzahrani NS, Almohammadi ME. The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics. J Family Med Prim Care 2019;8:3496-503 |
How to cite this URL: Alesa DI, Alshamrani HM, Alzahrani YA, Alamssi DN, Alzahrani NS, Almohammadi ME. The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics. J Family Med Prim Care [serial online] 2019 [cited 2021 Apr 12];8:3496-503. Available from: https://www.jfmpc.com/text.asp?2019/8/11/3496/270939 |

This article has been cited by | 1 |
Gut microbiome profile in psoriatic patients treated and untreated with biologic therapy |
|
| Virginia Valentini,Valentina Silvestri,Federica Marraffa,Giulia Greco,Agostino Bucalo,Sara Grassi,Antonella Gagliardi,Annamaria Mazzotta,Laura Ottini,Antonio Giovanni Richetta | | The Journal of Dermatology. 2021; | | [Pubmed] | [DOI] | | 2 |
Supporting young adults with psoriatic arthritis |
|
| Christine M. Galante | | Nursing. 2020; 50(11): 24 | | [Pubmed] | [DOI] | | 3 |
The Role of Gut Microbiome in Psoriasis: Oral Administration of Staphylococcus aureus and Streptococcus danieliae Exacerbates Skin Inflammation of Imiquimod-Induced Psoriasis-Like Dermatitis |
|
| Karin Okada,Yoshiaki Matsushima,Kento Mizutani,Keiichi Yamanaka | | International Journal of Molecular Sciences. 2020; 21(9): 3303 | | [Pubmed] | [DOI] | | 4 |
Nutrition and Psoriasis |
|
| Naoko Kanda,Toshihiko Hoashi,Hidehisa Saeki | | International Journal of Molecular Sciences. 2020; 21(15): 5405 | | [Pubmed] | [DOI] | |
|
 |
 |
|